comparemela.com

Latest Breaking News On - ஐயா கங்கா ரேம் - Page 9 : comparemela.com

Monoclonal antibody treatment for COVID-19 could be a game changer

Delhi hospital uses Monoclonal antibody therapy on two COVID-19 patients; discharges 12 hours later

Delhi hospital uses Monoclonal antibody therapy on two COVID-19 patients; discharges 12 hours later Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours BusinessToday.In | June 10, 2021 | Updated 14:58 IST Monoclonal antibodies are identical copies of an antibody that targets one specific antigen New Delhi s Sir Ganga Ram Hospital on Thursday reported successful usage of Monoclonal antibody therapy for treating two COVID-19 patients, The patients were suffering from fast progression of symptoms within the first seven days of the disease. Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours.

India records highest daily death toll

India reported on Thursday the highest single-day death toll from COVID-19 in the world, at 6,148, after a big eastern state revised its figures to account for people who succumbed to the disease at home or in private hospitals.

Monoclonal antibody therapy successful sir ganga ram hospital delhi patient discharged within 12 hours

URL copied Image Source : PTI Monoclonal antibody successfully used in 2 patients at Sir Ganga Ram hospital; one discharged within 12 hrs The monoclonal antibody therapy was successfully used in two patients at Delhi-based Sir Ganga Ram hospital. The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness.  According to a statement released by the hospital, the therapy was used in two patients with fast progression of symptoms within first seven days and it has changed the outcome . The hospital said that a 36-year-old healthcare worker who was down with high-grade fever, cough, myalgia, severe weakness and leucopenia was administered REGCov2 on day 6 of the disease. Patient s parameter improved within 12 hours and was discharged, it said. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.